Intermittent androgen deprivation therapy limits side effects, improves quality of life
November 1st 2008Intermittent androgen deprivation with a luteinizing hormone-releasing hormone analog causes fewer side effects and preserves quality of life compared with continuous combined androgen ablation, and many patients have prolonged treatment-free intervals.
Adjuvant chemo for bladder cancer: Are we closer to the truth?
November 1st 2008The value and timing of chemotherapy in patients undergoing cystectomy for clinically localized bladder cancer has long been controversial. There are myriad reasons supporting both neoadjuvant and adjuvant chemotherapies.
Near-infrared spectroscopy helps ID men classified as obstructed
October 23rd 2008An algorithm based on near-infrared spectroscopy (NIRS) is able to correctly identify more than 85% of men classified as obstructed, using catheter urodynamics, according to study findings published in the Canadian Journal of Urology (2008; 1515:4241-8).
Many patients misunderstand IPSS, other screening tests
October 23rd 2008A profound gap exists in the understanding of physicians about the literacy levels of their patients related to the efficacy of written screening tools, including the International Prostate Symptom Score, researchers from Emory University School of Medicine, Atlanta, reported.
FSH should not be factor in mTESE patient selection
October 15th 2008Elevated serum follicle-stimulating hormone does not predict a lower sperm retrieval rate for men with nonobstructive azoospermia undergoing microdissection tesÂticular sperm extraction, and should not be considered a contraindication for this fertility procedure.